Through a Crop of Fresh Hires, School of Medicine Brings New Medical Expertise to UB and to WNY Patients

New recruits will enhance patient care, medical education, basic and clinical research

Release Date: June 28, 2011 This content is archived.

Print

Related Multimedia

Ann B. Curtis, chair, UB Department of Medicine.

Lawrence Wrabetz, MD, director, UB's Hunter James Kelly Research Institute.

Margarita L. Dubocovich, PhD, chair, UB Department of Pharmacology and Toxicology.

Animesh Amart Sinha, MD, Phd, UB Department of Dermatology.

BUFFALO, N.Y. -- A new cadre of leaders is at the helm in departments throughout the University at Buffalo School of Medicine and Biomedical Sciences. Of the 26 academic departments in the UB medical school, nearly half of them are either being led by new chairs or are actively engaged in a search for one.

Since being named dean of the UB medical school in 2006, when he came to UB from Washington University in St. Louis, Michael E. Cain, MD, has appointed half a dozen new chairs and high-level physician-scientists, many from outside the state. Four additional searches for new chairs are now underway in the departments of neurology, gynecology-obstetrics, radiology, and microbiology and immunology.

The hiring of many of these new department leaders is supported through the generous contributions of UB donors, Cain notes.

New leadership, Cain says, is a critical piece of his strategic vision for the medical school and will have a dramatic effect on all of the school's missions: educating tomorrow's leaders in health care and biomedical sciences, conducting innovative research and performing outstanding clinical care for the people of Western New York.

The new recruits also are filling in some gaps in both research and clinical care. With the passage of the NYSUNY 2020 bill by the state legislature last week, which approved UB's proposal to construct a new medical school in downtown Buffalo, the department chairs will be taking an active role in planning the school's move into a new state-of-the-art-facility.

"Department chairs are the keystone of a school of medicine," explains Cain. "It is our responsibility to recruit a new breed of visionary department leaders to fulfill our mission of advancing health and wellness for the people of New York State and the world.

"We will do this by educating tomorrow's leaders in health care and biomedical sciences, conducting innovative research and providing outstanding clinical care to Western New York. These new recruits will build robust departments of exceptional basic scientists, educators and clinicians who will, in turn, attract the best students."

Cain says the Western New York population also stands to gain from the new clinical expertise that the chairs and their faculty bring to the community through UBMD -- the practice plan through which UB faculty physicians provide care to patients -- and through the local hospitals, where UB faculty and more than 800 medical residents work as attending physicians.

"These physicians and scientists are bringing their world-class expertise directly to the people of Western New York, when they care for patients served through UBMD and through our hospital partners," says Cain, who, in addition to being dean, will assume the position of UB vice president for health sciences on July 1.

The new hires include an internationally recognized leader in cardiac electrophysiology, an expert in melatonin and its therapeutic effects, and a pioneer in myelin biology who will conduct research on Krabbe's disease.

In June, Cain named John E. Tomaszewski, MD, professor of pathology and laboratory medicine and interim chair of the Department of Pathology and Laboratory Medicine at the University of Pennsylvania School of Medicine, to chair the UB Department of Pathology and Anatomical Sciences, effective Oct. 1. Tomaszewski conducts research in genitourinary malignancies and immunopathology, especially in renal transplantation and advanced tissue image analysis.

In the fall, Cain will initiate a search for a chair of the Department of Physiology and Biophysics.

The other high-profile appointments at the UB school of medicine at the chair or equivalent level include:

-- Anne B. Curtis, MD, formerly professor of medicine at University of South Florida, chief of the USF's Division of Cardiology and director of Cardiovascular Services, who was recruited last summer to UB to chair the Department of Medicine and serve as the department's inaugural Mary and Charles Bauer Professor. One of the world's leading clinical cardiac electrophysiologists and an expert in cardiac arrhythmias, she plays an important role in developing national guidelines for treating atrial fibrillation.

-- Animesh Amart Sinha, MD, PhD, formerly chief of the N.V. Perricone Division of Dermatology and Cutaneous Sciences at Michigan State University and director of its Center for Investigative Dermatology, recruited to UB in April to chair the Department of Dermatology at UB and Roswell Park Cancer Institute and to become UB's inaugural Rita M. and Ralph T. Behling, MD, Professor of Dermatology. He is an expert in the fields of immunological tolerance and autoimmunity in skin diseases, such as alopecia lupus, psoriasis and others.

-- Lawrence Wrabetz, MD, former head of the myelin biology unit at San Raffaele Scientific Institute in Milan, Italy, who last fall was appointed director of UB's Hunter James Kelly Research Institute (HJKRI), which was established in 2004 by UB and the Hunter's Hope Foundation. HJKRI conducts research on remyelination techniques and the biology and pathophysiology of Krabbe Disease, with the goal of discovering ways to correct the genetic defect responsible for Krabbe Disease and other leukodystrophies and of developing effective treatments. Laura Feltri, MD, who heads the neuroglia unit at the Italian institute and is Wrabetz's spouse, also was recruited to the HJKRI.

-- Margarita L. Dubocovich, PhD, an internationally recognized expert in molecular pharmacology and drug discovery, recruited to UB in fall 2008 to chair the UB Department of Pharmacology and Toxicology from Northwestern University's Feinberg School of Medicine, where she was professor of molecular pharmacology and biological chemistry and psychiatry. She pioneered the discovery of drugs to assess the functional role of certain melatonin receptors -- and in the identification of ligands with the potential for treating depression, seasonal affective disorders, sleep and circadian disorders, and cancer.

-- Teresa Quattrin, MD, UB professor of pediatrics, named chair of the Department of Pediatrics, housed in Women and Children's Hospital of Buffalo, in February 2010. Quattrin, an internationally known physician-scientist and an expert in childhood diabetes and obesity, also serves as Kaleida Health's pediatrician-in-chief, chief of the department's Division of Pediatric Endocrinology and director of the WCHOB Diabetes Center.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB's more than 28,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs. Founded in 1846, the University at Buffalo is a member of the Association of American Universities.

Media Contact Information

John Della Contrada
Vice President for University Communications
521 Capen Hall
Buffalo, NY 14260
Tel: 716-645-4094 (mobile: 716-361-3006)
dellacon@buffalo.edu
Twitter: UBNewsSource